Your browser doesn't support javascript.
loading
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Mease, Philip; Charles-Schoeman, Christina; Cohen, Stanley; Fallon, Lara; Woolcott, John; Yun, Huifeng; Kremer, Joel; Greenberg, Jeffrey; Malley, Wendi; Onofrei, Alina; Kanik, Keith S; Graham, Daniela; Wang, Cunshan; Connell, Carol; Valdez, Hernan; Hauben, Manfred; Hung, Eric; Madsen, Ann; Jones, Thomas V; Curtis, Jeffrey R.
Afiliação
  • Mease P; Rheumatology Clinical Research Division, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA pmease@philipmease.com.
  • Charles-Schoeman C; Division of Rheumatology, University of California, Los Angeles, California, USA.
  • Cohen S; Metroplex Research Center, Dallas, Texas, USA.
  • Fallon L; Inflammation and Immunology - Global Medical Affairs, Pfizer Inc, Kirkland, Quebec, Canada.
  • Woolcott J; Inflammation and Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Yun H; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Kremer J; Albany Medical College and The Center for Rheumatology, Albany, New York, USA.
  • Greenberg J; Corrona LLC, Waltham, Massachusetts, USA.
  • Malley W; Corrona LLC, Waltham, Massachusetts, USA.
  • Onofrei A; Corrona LLC, Waltham, Massachusetts, USA.
  • Kanik KS; Inflammation and Immunology TA, Pfizer Inc, Groton, Connecticut, USA.
  • Graham D; Inflammation and Immunology TA, Pfizer Inc, Groton, Connecticut, USA.
  • Wang C; Statistics, Global Product Development, Pfizer Inc, Groton, Connecticut, USA.
  • Connell C; Clinical Development & Operations, Pfizer Inc, Groton, Connecticut, USA.
  • Valdez H; Global Product Development, Inflammation and Immunology, Pfizer Inc, New York, New York, USA.
  • Hauben M; Worldwide Safety, Pfizer Inc, New York, New York, USA.
  • Hung E; Department of Medicine, NYU Langone Health, New York, New York, USA.
  • Madsen A; Worldwide Safety, Pfizer Inc, New York, New York, USA.
  • Jones TV; Global Medical Epidemiology, Pfizer Inc, New York, New York, USA.
  • Curtis JR; Worldwide Medical and Safety, Pfizer Inc, Collegeville, Pennsylvania, USA.
Ann Rheum Dis ; 79(11): 1400-1413, 2020 11.
Article em En | MEDLINE | ID: mdl-32759265
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirimidinas / Pirróis / Tromboembolia / Doenças Reumáticas / Inibidores de Proteínas Quinases Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirimidinas / Pirróis / Tromboembolia / Doenças Reumáticas / Inibidores de Proteínas Quinases Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos